Canada Life’s Accolade Inc ACCD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-5,968
Closed -$21K 2090
2024
Q2
$21K Hold
5,968
﹤0.01% 2032
2024
Q1
$63K Hold
5,968
﹤0.01% 1995
2023
Q4
$71K Hold
5,968
﹤0.01% 2007
2023
Q3
$63K Buy
5,968
+4,452
+294% +$58.4K ﹤0.01% 2049
2023
Q2
$21K Sell
1,516
-2,093
-58% -$27.2K ﹤0.01% 2140
2023
Q1
$52K Hold
3,609
﹤0.01% 2061
2022
Q4
$28K Buy
3,609
+1,842
+104% +$17.6K ﹤0.01% 2196
2022
Q3
$20K Hold
1,767
﹤0.01% 2266
2022
Q2
$13K Hold
1,767
﹤0.01% 2339
2022
Q1
$33K Hold
1,767
﹤0.01% 2258
2021
Q4
$46K Hold
1,767
﹤0.01% 2197
2021
Q3
$75K Hold
1,767
﹤0.01% 2125
2021
Q2
$96K Buy
1,767
+845
+92% +$41K ﹤0.01% 2097
2021
Q1
$41K Hold
922
﹤0.01% 2355
2020
Q4
$40K Buy
+922
New +$40.9K ﹤0.01% 2362

Other funds holding ACCD

Canada Life's ACCD Position: Q3 2024 in Review

Canada Life sold out of Accolade Inc (ACCD) in Q3 2024, closing a stake of 5,968 shares — an estimated $21K sold.

Canada Life first reported a position in ACCD in Q4 2020 and held it in 15 quarters. The position peaked at $96K in Q2 2021. 150 funds tracked by Wall St. Rank hold ACCD as of Q3 2024.

  • Canada Life reported no remaining Accolade Inc position as of Q3 2024 after selling out during the quarter.
  • Canada Life sold 5,968 Accolade Inc shares in Q3 2024, an estimated $21K.
  • Canada Life first reported a position in Accolade Inc in Q4 2020 and held it in 15 quarters.
  • Canada Life's Accolade Inc position peaked at $96K in Q2 2021.
  • 150 funds tracked by Wall St. Rank held Accolade Inc as of Q3 2024.

Based on Canada Life's 13F filing for Q3 2024, filed 13 Nov 2024.